U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Americare Compounding, LLC. - 02/06/2017
  1. Warning Letters

CLOSEOUT LETTER

Americare Compounding, LLC.

Recipient:
Americare Compounding, LLC.

United States

Issuing Office:

United States

 

  

Black HHS-Blue FDA Logo

 

 

 
New York District
158-15 Liberty Ave
Jamaica, NY 11433 

2/6/2017

Thomas D'Angelo, Co-Owner/Pharmacist
Americare Compounding, LLC
319 Nassau Blvd
Garden City South, NY 11530-5313

Dear Mr. D'Angelo,

The Food and Drug Administration has completed an evaluation of your corrective actions in response to our warning letter (NYK-2014-29, April 22, 2014). Based on our evaluation, it appears that you have adequately addressed the violations contained in this warning letter.

You are expected to take all necessary steps to assure compliance with the Federal Food, Drug, and Cosmetic Act and FDA's implementing regulations. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely,
/S/

Ronald M. Pace
District Director
New York District 

Back to Top